Anger experiences among hepatitis C patients: Relationship to depressive symptoms and health-related quality of life

Amy A. Dan; Cathy Crone; Thomas N. Wise; Lisa M. Martin; Lolita Ramsey; Scarlett Magee; Robert Sjogren; Janus P. Ong; Zobair M. Younossi

doi:10.1176/appi.psy.48.3.223

Anger experiences among hepatitis C patients: Relationship to depressive symptoms and health-related quality of life

Amy A. Dan, Cathy Crone, Thomas N. Wise, Lisa M. Martin, Lolita Ramsey, Scarlett Magee, Robert Sjogren, Janus P. Ong, Zobair M. Younossi

Research output: Contribution to journal › Article › peer-review

39 Scopus citations

Abstract

The authors examined anger among hepatitis C (HCV) patients and its relationship to health-related quality of life (HRQL) and depression. Eighty-seven HCV patients who received pegylated interferon-alpha_2b and ribavirin were included. Patients' mean age was 48 years; 42% were women, and 60% were white. Patients experienced moderate anger while undergoing HCV treatment. Angry feelings increased during treatment in some domains, specifically, Control Over Anger and Angry Reaction. Greater anger was associated with more depression and poorer HRQL. Findings point to the importance for physicians to screen for a wide range of neuropsychiatric side effects of interferon, including anger.

Original language	English (US)
Pages (from-to)	223-229
Number of pages	7
Journal	Psychosomatics
Volume	48
Issue number	3
DOIs	https://doi.org/10.1176/appi.psy.48.3.223
State	Published - 2007
Externally published	Yes

ASJC Scopus subject areas

Arts and Humanities (miscellaneous)
Applied Psychology
Psychiatry and Mental health

Access to Document

10.1176/appi.psy.48.3.223

Cite this

@article{90d77c1506f8412ead7fe2b25c4eb71e,

title = "Anger experiences among hepatitis C patients: Relationship to depressive symptoms and health-related quality of life",

abstract = "The authors examined anger among hepatitis C (HCV) patients and its relationship to health-related quality of life (HRQL) and depression. Eighty-seven HCV patients who received pegylated interferon-alpha2b and ribavirin were included. Patients' mean age was 48 years; 42% were women, and 60% were white. Patients experienced moderate anger while undergoing HCV treatment. Angry feelings increased during treatment in some domains, specifically, Control Over Anger and Angry Reaction. Greater anger was associated with more depression and poorer HRQL. Findings point to the importance for physicians to screen for a wide range of neuropsychiatric side effects of interferon, including anger.",

author = "Dan, {Amy A.} and Cathy Crone and Wise, {Thomas N.} and Martin, {Lisa M.} and Lolita Ramsey and Scarlett Magee and Robert Sjogren and Ong, {Janus P.} and Younossi, {Zobair M.}",

note = "Funding Information: This research was partially supported by grants from the Liver Outcomes Research Fund ; Inova Health Systems Foundation ; and Amgen, Thousand Oaks, CA. ",

year = "2007",

doi = "10.1176/appi.psy.48.3.223",

language = "English (US)",

volume = "48",

pages = "223--229",

journal = "Psychosomatics",

issn = "0033-3182",

publisher = "American Psychiatric Publishing Inc.",

number = "3",

}

TY - JOUR

T1 - Anger experiences among hepatitis C patients

T2 - Relationship to depressive symptoms and health-related quality of life

AU - Dan, Amy A.

AU - Crone, Cathy

AU - Wise, Thomas N.

AU - Martin, Lisa M.

AU - Ramsey, Lolita

AU - Magee, Scarlett

AU - Sjogren, Robert

AU - Ong, Janus P.

AU - Younossi, Zobair M.

N1 - Funding Information: This research was partially supported by grants from the Liver Outcomes Research Fund ; Inova Health Systems Foundation ; and Amgen, Thousand Oaks, CA.

PY - 2007

Y1 - 2007

N2 - The authors examined anger among hepatitis C (HCV) patients and its relationship to health-related quality of life (HRQL) and depression. Eighty-seven HCV patients who received pegylated interferon-alpha2b and ribavirin were included. Patients' mean age was 48 years; 42% were women, and 60% were white. Patients experienced moderate anger while undergoing HCV treatment. Angry feelings increased during treatment in some domains, specifically, Control Over Anger and Angry Reaction. Greater anger was associated with more depression and poorer HRQL. Findings point to the importance for physicians to screen for a wide range of neuropsychiatric side effects of interferon, including anger.

AB - The authors examined anger among hepatitis C (HCV) patients and its relationship to health-related quality of life (HRQL) and depression. Eighty-seven HCV patients who received pegylated interferon-alpha2b and ribavirin were included. Patients' mean age was 48 years; 42% were women, and 60% were white. Patients experienced moderate anger while undergoing HCV treatment. Angry feelings increased during treatment in some domains, specifically, Control Over Anger and Angry Reaction. Greater anger was associated with more depression and poorer HRQL. Findings point to the importance for physicians to screen for a wide range of neuropsychiatric side effects of interferon, including anger.

UR - http://www.scopus.com/inward/record.url?scp=34248665273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248665273&partnerID=8YFLogxK

U2 - 10.1176/appi.psy.48.3.223

DO - 10.1176/appi.psy.48.3.223

M3 - Article

C2 - 17478591

AN - SCOPUS:34248665273

SN - 0033-3182

VL - 48

SP - 223

EP - 229

JO - Psychosomatics

JF - Psychosomatics

IS - 3

ER -

Anger experiences among hepatitis C patients: Relationship to depressive symptoms and health-related quality of life

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this